{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:39:25Z","timestamp":1767983965700,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Cancer Institute","award":["Contract HHSN261201700690P"],"award-info":[{"award-number":["Contract HHSN261201700690P"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00520-019-05074-8","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T13:03:59Z","timestamp":1571663039000},"page":"3061-3072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Patterns of pain medication use associated with reported pain interference in older adults with and without cancer"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-9249","authenticated-orcid":false,"given":"Amy J.","family":"Davidoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen E.","family":"Canavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelli","family":"Feder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Sheinfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kapo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn J.","family":"Presley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"5074_CR1","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jpain.2014.05.009","volume":"15","author":"J Kennedy","year":"2014","unstructured":"Kennedy J, Roll JM, Schraudner T, Murphy S, McPherson S (2014) Prevalence of persistent pain in the U.S. adult population: new data from the 2010 national health interview survey. J Pain 15:979\u2013984","journal-title":"J Pain"},{"key":"5074_CR2","volume-title":"Relieving pain in America: a blueprint for transforming prevention, care, education, and research","author":"Institute of Medicine","year":"2011","unstructured":"Institute of Medicine (2011) Relieving pain in America: a blueprint for transforming prevention, care, education, and research. National Academies of Science and Medicine, Washington, DC"},{"key":"5074_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1526-4637.2006.00220.x","volume":"8","author":"AW Burton","year":"2007","unstructured":"Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ (2007) Chronic pain in the cancer survivor: a new frontier. Pain Med 8:189\u2013198","journal-title":"Pain Med"},{"key":"5074_CR4","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","volume":"19","author":"S Deandrea","year":"2008","unstructured":"Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19:1985\u20131991","journal-title":"Ann Oncol"},{"key":"5074_CR5","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.2147\/JPR.S139715","volume":"10","author":"P Reis-Pina","year":"2017","unstructured":"Reis-Pina P, Lawlor PG, Barbosa A (2017) Adequacy of cancer-related pain management and predictors of undertreatment at referral to a pain clinic. J Pain Res 10:2097\u20132107","journal-title":"J Pain Res"},{"key":"5074_CR6","first-page":"4149","volume":"32","author":"MT Greco","year":"2014","unstructured":"Greco MT, Roberto A, Corli O, Deandrea S, Bandieri E, Cavuto S, Apolone G (2014) Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Oncol Pract 32:4149\u20134154","journal-title":"J Oncol Pract"},{"key":"5074_CR7","first-page":"1095","volume":"30","author":"L Barbera","year":"2012","unstructured":"Barbera L, Seow H, Husain A, Howell D, Atzema C, Sutradhar R, Earle C, Sussman J, Liu Y, Dudgeon D (2012) Opioid prescription after pain assessment: a population-based cohort of elderly patients with cancer. J Oncol Pract 30:1095\u20131099","journal-title":"J Oncol Pract"},{"key":"5074_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jpainsymman.2018.03.010","volume":"56","author":"L Barbera","year":"2018","unstructured":"Barbera L, Sutradhar R, Chu A, Seow H, Howell D, Earle CC, O'Brien MA, Dudgeon D, Atzema C, Husain A, Liu Y, DeAngelis C (2018) Comparison of opioid prescribing among cancer and noncancer patients aged 18-64: analysis using administrative data. J Pain Symptom Manag 56:72\u201379","journal-title":"J Pain Symptom Manag"},{"key":"5074_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jpainsymman.2017.07.017","volume":"54","author":"L Barbera","year":"2017","unstructured":"Barbera L, Sutradhar R, Chu A, Seow H, Howell D, Earle CC, O'Brien MA, Dudgeon D, Atzema C, Husain A, Liu Y, DeAngelis C (2017) Opioid prescribing among cancer and non-cancer patients: time trend analysis in the elderly using administrative data. J Pain Symptom Manag 54:484\u2013492","journal-title":"J Pain Symptom Manag"},{"key":"5074_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2105\/AJPH.2018.304349","volume":"108","author":"JM Harrison","year":"2018","unstructured":"Harrison JM, Lagisetty P, Sites BD, Guo C, Davis MA (2018) Trends in prescription pain medication use by race\/ethnicity among US adults with noncancer pain, 2000-2015. Am J Public Health 108:788\u2013790","journal-title":"Am J Public Health"},{"key":"5074_CR11","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1002\/cncr.30839","volume":"123","author":"R Sutradhar","year":"2017","unstructured":"Sutradhar R, Lokku A, Barbera L (2017) Cancer survivorship and opioid prescribing rates: a population-based matched cohort study among individuals with and without a history of cancer. Cancer 123:4286\u20134293","journal-title":"Cancer"},{"key":"5074_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jpain.2017.11.001","volume":"19","author":"N Moryl","year":"2018","unstructured":"Moryl N, Dave V, Glare P, Bokhari A, Malhotra VT, Gulati A, Hung J, Puttanniah V, Griffo Y, Tickoo R, Wiesenthal A, Horn SD, Inturrisi CE (2018) Patient-reported outcomes and opioid use by outpatient cancer patients. J Pain 19:278\u2013290","journal-title":"J Pain"},{"key":"5074_CR13","first-page":"5","volume":"29","author":"A Ambs","year":"2008","unstructured":"Ambs A, Warren JL, Bellizzi KM, Topor M, Haffer SC, Clauser SB (2008) Overview of the SEER--medicare health outcomes survey linked dataset. Health Care Financ Rev 29:5\u201321","journal-title":"Health Care Financ Rev"},{"key":"5074_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cncr.29119","volume":"121","author":"EE Kent","year":"2015","unstructured":"Kent EE, Ambs A, Mitchell SA, Clauser SB, Smith AW, Hays RD (2015) Health-related quality of life in older adult survivors of selected cancers: data from the SEER-MHOS linkage. Cancer 121:758\u2013765","journal-title":"Cancer"},{"key":"5074_CR15","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1007\/s00520-016-3174-6","volume":"24","author":"DK Check","year":"2016","unstructured":"Check DK, Rosenstein DL, Dusetzina SB (2016) Early supportive medication use and end-of-life care among Medicare beneficiaries with advanced breast cancer. Support Care Cancer 24:3463\u20133472","journal-title":"Support Care Cancer"},{"key":"5074_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.6004\/jnccn.2014.0054","volume":"12","author":"CS Denlinger","year":"2014","unstructured":"Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe M, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D, National Comprehensive Cancer Network (2014) Survivorship: pain version 1.2014. J Natl Compr Cancer Netw 12:488\u2013500","journal-title":"J Natl Compr Cancer Netw"},{"key":"5074_CR17","volume-title":"Calculating total daily dose","author":"Centers for Disease Control and Prevention","year":"2017","unstructured":"Centers for Disease Control and Prevention (2017) Calculating total daily dose. Centers for Disease Control and Prevention, Atlanta"},{"key":"5074_CR18","volume-title":"Opioid oral morphine milligram equivalent (MME) conversion factors","author":"Center for Medicare & Medicaid Services","year":"2017","unstructured":"Center for Medicare & Medicaid Services (2017) Opioid oral morphine milligram equivalent (MME) conversion factors. Centers for Medicare and Medicaid Services, Baltimore"},{"key":"5074_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","volume":"65","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R (2016) CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep 65:1\u201349","journal-title":"MMWR Recomm Rep"},{"key":"5074_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/082585979100700202","volume":"7","author":"E Bruera","year":"1991","unstructured":"Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6\u20139","journal-title":"J Palliat Care"},{"key":"5074_CR21","first-page":"1980","volume":"30","author":"MJ Fisch","year":"2012","unstructured":"Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS (2012) Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Oncol Pract 30:1980\u20131988","journal-title":"J Oncol Pract"},{"key":"5074_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2354.2006.00768.x","volume":"17","author":"W Brown","year":"2008","unstructured":"Brown W (2008) Opioid use in dying patients in hospice and hospital, with and without specialist palliative care team involvement. Eur J Cancer Care (Engl) 17:65\u201371","journal-title":"Eur J Cancer Care (Engl)"},{"key":"5074_CR23","first-page":"e13","volume":"5","author":"T Gomes","year":"2011","unstructured":"Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani MM (2011) Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med 5:e13\u2013e22","journal-title":"Open Med"},{"key":"5074_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","volume":"66","author":"GP Guy Jr","year":"2017","unstructured":"Guy GP Jr, Zhang K, Bohm MK, Losby J, Lewis B, Young R, Murphy LB, Dowell D (2017) Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep 66:697\u2013704","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5074_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s11606-014-3143-z","volume":"30","author":"HJ Mosher","year":"2015","unstructured":"Mosher HJ, Krebs EE, Carrel M, Kaboli PJ, Weg MWV, Lund BC (2015) Trends in prevalent and incident opioid receipt: an observational study in veterans health administration 2004-2012. J Gen Intern Med 30:597\u2013604","journal-title":"J Gen Intern Med"},{"key":"5074_CR26","first-page":"45","volume":"110","author":"I Schubert","year":"2013","unstructured":"Schubert I, Ihle P, Sabatowski R (2013) Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data. Dtsch Arztebl Int 110:45\u201351","journal-title":"Dtsch Arztebl Int"},{"key":"5074_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/pds.3989","volume":"25","author":"K Smolina","year":"2016","unstructured":"Smolina K, Gladstone E, Morgan SG (2016) Determinants of trends in prescription opioid use in British Columbia, Canada, 2005-2013. Pharmacoepidemiol Drug Saf 25:553\u2013559","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"5074_CR28","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1200\/JOP.2017.025494","volume":"13","author":"L Barbera","year":"2017","unstructured":"Barbera L, Sutradhar R, Chu A, Seow H, Earle CC, O\u2019Brien MA, Dudgeon D, DeAngelis C, Atzema C, Husain A, Liu Y, Howell D (2017) Has province-wide symptom screening changed opioid prescribing rates in older patients with cancer? J Oncol Pract 13:e927\u2013e934","journal-title":"J Oncol Pract"},{"key":"5074_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1365-2354.2005.00624.x","volume":"15","author":"A Berger","year":"2006","unstructured":"Berger A, Dukes E, Mercadante S et al (2006) Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care (Engl) 15:138\u2013145","journal-title":"Eur J Cancer Care (Engl)"},{"key":"5074_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0885-3924(03)00255-0","volume":"26","author":"A Berger","year":"2003","unstructured":"Berger A, Dukes E, Smith M, Hagiwara M, Seifeldin R, Oster G (2003) Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life. J Pain Symptom Manag 26:723\u2013730","journal-title":"J Pain Symptom Manag"},{"key":"5074_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jpainsymman.2014.05.015","volume":"49","author":"B Gagnon","year":"2015","unstructured":"Gagnon B, Scott S, Nadeau L, Lawlor PG (2015) Patterns of community-based opioid prescriptions in people dying of cancer. J Pain Symptom Manag 49:36\u201344","journal-title":"J Pain Symptom Manag"},{"key":"5074_CR32","first-page":"4373","volume":"30","author":"IJ Higginson","year":"2012","unstructured":"Higginson IJ, Gao W (2012) Opioid prescribing for cancer pain during the last 3 months of life: associated factors and 9-year trends in a nationwide United Kingdom cohort study. J Oncol Pract 30:4373\u20134379","journal-title":"J Oncol Pract"},{"key":"5074_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clon.2009.12.002","volume":"22","author":"L Jarlbaek","year":"2010","unstructured":"Jarlbaek L, Hansen DG, Bruera E, Andersen M (2010) Frequency of opioid use in a population of cancer patients during the trajectory of the disease. Clin Oncol (R Coll Radiol) 22:199\u2013207","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"5074_CR34","first-page":"1677","volume":"32","author":"J Vardy","year":"2014","unstructured":"Vardy J, Agar M (2014) Nonopioid drugs in the treatment of cancer pain. J Oncol Pract 32:1677\u20131690","journal-title":"J Oncol Pract"},{"key":"5074_CR35","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1097\/j.pain.0000000000000656","volume":"157","author":"L Ziegler","year":"2016","unstructured":"Ziegler L, Mulvey M, Blenkinsopp A, Petty D, Bennett MI (2016) Opioid prescribing for patients with cancer in the last year of life: a longitudinal population cohort study. Pain 157:2445\u20132451","journal-title":"Pain"},{"key":"5074_CR36","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.2105\/AJPH.2009.180646","volume":"100","author":"CI Campbell","year":"2010","unstructured":"Campbell CI, Weisner C, Leresche L et al (2010) Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health 100:2541\u20132547","journal-title":"Am J Public Health"},{"key":"5074_CR37","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.17269\/CJPH.107.5413","volume":"107","author":"K Smolina","year":"2016","unstructured":"Smolina K, Gladstone EJ, Rutherford K, Morgan SG (2016) Patterns and trends in long-term opioid use for non-cancer pain in British Columbia, 2005-2012. Can J Public Health 107:e404\u2013e409","journal-title":"Can J Public Health"},{"key":"5074_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/0033354916688206","volume":"132","author":"S Wickramatilake","year":"2017","unstructured":"Wickramatilake S, Zur J, Mulvaney-Day N, Klimo MC, Selmi E, Harwood H (2017) How states are tackling the opioid crisis. Public Health Rep 132:171\u2013179","journal-title":"Public Health Rep"},{"key":"5074_CR39","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1377\/hlthaff.2015.1496","volume":"35","author":"SW Patrick","year":"2016","unstructured":"Patrick SW, Fry CE, Jones TF, Buntin MB (2016) Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff (Project Hope) 35:1324\u20131332","journal-title":"Health Aff (Project Hope)"},{"key":"5074_CR40","doi-asserted-by":"publisher","first-page":"813","DOI":"10.7326\/0003-4819-127-9-199711010-00006","volume":"127","author":"CS Cleeland","year":"1997","unstructured":"Cleeland CS, Gonin R, Baez L et al (1997) Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med 127:813\u2013816","journal-title":"Ann Intern Med"},{"key":"5074_CR41","first-page":"s78","volume":"22","author":"JA Doshi","year":"2016","unstructured":"Doshi JA, Li P, Huo H, Pettit AR, Kumar R, Weiss BM, Huntington SF (2016) High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemia. Am J Manag Care 22:s78\u2013s86","journal-title":"Am J Manag Care"},{"key":"5074_CR42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1200\/JCO.2013.52.9123","volume":"32","author":"SB Dusetzina","year":"2014","unstructured":"Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL (2014) Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 32:306\u2013311","journal-title":"J Clin Oncol"},{"key":"5074_CR43","first-page":"3306","volume":"35","author":"AJ Olszewski","year":"2017","unstructured":"Olszewski AJ, Dusetzina SB, Eaton CB, Davidoff AJ, Trivedi AN (2017) Subsidies for oral chemotherapy and use of immunomodulatory drugs among Medicare beneficiaries with myeloma. J Oncol Pract 35:3306\u20133314","journal-title":"J Oncol Pract"},{"key":"5074_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/pme.12238","volume":"15","author":"R Wieder","year":"2014","unstructured":"Wieder R, Delarosa N, Bryan M et al (2014) Prescription coverage in indigent patients affects the use of long-acting opioids in the management of cancer pain. Pain Med 15:42\u201351","journal-title":"Pain Med"},{"key":"5074_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","volume":"176","author":"DM Qato","year":"2016","unstructured":"Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC (2016) Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med 176:473\u2013482","journal-title":"JAMA Intern Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05074-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-019-05074-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05074-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T20:11:43Z","timestamp":1650399103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-019-05074-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5074"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-05074-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"24 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"EEK was a contractor for NCI and assisted with project oversight as well as contributing substantial intellectual input. AJD\u2019s institution receives research funding from Celgene Corporation outside of the submitted project. CJP is a Paul Calabresi Scholar supported by the OSU K12 Training Grant for Clinical Faculty Investigators (K12 CA133250) and is a consultant for Potentia Metrics. SW\u2019s institution receives funding from Genentech to support his research. No other author reports any conflict of interest to disclose. The research team had direct control of the data throughout the study project. We are unable to release the data to other researcher due to constraints of the Data Use Agreement with the NCI. However, we would be willing to provide SAS code for selection of medications identified in the analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The interpretation and reporting of these data are the sole responsibility of the authors and do not reflect the positions of the National Cancer Institute, the Centers for Medicare & Medicaid Services, or the U.S. Department of Health and Human Services.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}